Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Hamacher

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2023
Superior Tumor Detection for <sup>68</sup>Ga-FAPI-46 Versus <sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M Pabst, Marija Trajkovic-Arsic, Phyllis F Y Cheung, et al.
Cancer Treatment and Research Communications|September 11, 2025
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trialChristoph E Heilig, Christoph Heining, Editha Gnutzmann, et al.
Annals of Nuclear Medicine|October 23, 2024
Head-to-head comparison of <sup>68</sup> Ga-FAPI-46 PET/CT, <sup>18</sup>F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsMasao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
Fibroblast Activation Protein-Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational TrialLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Theranostics|September 23, 2024
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of <sup>68</sup>Ga-SSO120 PET with immunohistochemistry and survivalIlektra Antonia Mavroeidi, Anna Romanowicz, Tristan Haake, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Diagnostic Accuracy of <sup>68</sup>Ga-FAPI Versus <sup>18</sup>F-FDG PET in Patients with Various MalignanciesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2023
Superior Tumor Detection for <sup>68</sup>Ga-FAPI-46 Versus <sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M Pabst, Marija Trajkovic-Arsic, Phyllis F Y Cheung, et al.
Cancer Treatment and Research Communications|September 11, 2025
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trialChristoph E Heilig, Christoph Heining, Editha Gnutzmann, et al.
Annals of Nuclear Medicine|October 23, 2024
Head-to-head comparison of <sup>68</sup> Ga-FAPI-46 PET/CT, <sup>18</sup>F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsMasao Watanabe, Wolfgang P Fendler, Hong Grafe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
Fibroblast Activation Protein-Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational TrialLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Theranostics|September 23, 2024
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of <sup>68</sup>Ga-SSO120 PET with immunohistochemistry and survivalIlektra Antonia Mavroeidi, Anna Romanowicz, Tristan Haake, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Diagnostic Accuracy of <sup>68</sup>Ga-FAPI Versus <sup>18</sup>F-FDG PET in Patients with Various MalignanciesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2024
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Kim M Pabst, Phyllis F Cheung, et al.
Pageof 7